UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048035
Receipt number R000054748
Scientific Title Development of a method for identification of people at high risk of ulcerative colitis by analysis of a large residential cohort.
Date of disclosure of the study information 2022/08/01
Last modified on 2022/12/12 10:31:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of a method for identification of people at high risk of ulcerative colitis by analysis of a large residential cohort.

Acronym

Method for determining risk of ulcerative colitis

Scientific Title

Development of a method for identification of people at high risk of ulcerative colitis by analysis of a large residential cohort.

Scientific Title:Acronym

Method for determining risk of ulcerative colitis

Region

Japan


Condition

Condition

Ulcerative Colitis

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

We will examine whether early diagnosis of ulcerative colitis by blood autoantibodies is possible using anti-EPCR antibody titer before the onset of ulcerative colitis as the primary endpoint. Furthermore, using samples and information before and after the onset of inflammatory bowel disease, we will conduct metabolomic analysis, proteomic analysis, genomic analysis, and analysis of dietary and lifestyle information to search for risk factors and biomarkers to predict high-risk patients and to develop prediction methods for high-risk patients.

Basic objectives2

Others

Basic objectives -Others

exploratory study

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Sensitivity and specificity as the positive rate of autoantibody titers in new onset cases and the ability to diagnose before the onset of disease.

Key secondary outcomes

Genetic and clinical risk factors for pathogenesis of inflammatory bowel diseases


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Participants of the Tohoku University Tohoku Medical Megabank Organization community cohort and three-generation cohort
(2) Either serum samples or SNP array data are stored.
(3) New cases of inflammatory bowel disease are those who have no history of inflammatory bowel disease (ulcerative colitis or Crohn's disease) on the baseline questionnaire in the cohort study and whose intractable disease application of inflammatory bowel disease was subsequently approved
(4) Cases with a history of inflammatory bowel disease are those with a history of inflammatory bowel disease (ulcerative colitis or Crohn's disease) confirmed in the baseline questionnaire in the cohort study.

Key exclusion criteria

(1) Cases who declined to participate in this study (opt-out cases)
(2) Cases in which the principal investigator determines that the subject is inappropriate for the study (e.g., cases with a large number of missing data and cases in which analysis is extremely difficult)
(3) Cases in which the patient is found to have already died
(4) Cases in which the subject is a withdrawer of consent for a cohort study

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Yoichi
Middle name
Last name Kakuta

Organization

Tohoku University Hospital

Division name

Division of Gastroenterology

Zip code

9808574

Address

1-1 Seiryo Aoba, Sendai, Japan

TEL

0227177171

Email

ykakuta@med.tohoku.ac.jp


Public contact

Name of contact person

1st name Motoi
Middle name
Last name Sawahashi

Organization

Tohoku University Hospital

Division name

Division of Gastroenterology

Zip code

9808574

Address

1-1 Seiryo Aoba, Sendai, Japan

TEL

0227177171

Homepage URL


Email

mt.sawahashi@gmail.com


Sponsor or person

Institute

Tohoku University

Institute

Department

Personal name



Funding Source

Organization

Tohoku University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee Tohoku University Graduate School of Medicine

Address

2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan

Tel

022-717-8007

Email

med-kenkyo@grp.tohoku.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2022 Year 07 Month 30 Day

Date of IRB

2022 Year 07 Month 30 Day

Anticipated trial start date

2022 Year 10 Month 01 Day

Last follow-up date

2022 Year 10 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Retrospective study using existing sample and information


Management information

Registered date

2022 Year 06 Month 12 Day

Last modified on

2022 Year 12 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054748


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name